EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
Umemori K, Ono K, Eguchi T, Kawai H, Nakamura T, Ogawa T, Yoshida K, Kanemoto H, Sato K, Obata K, Ryumon S, Yutori H, Katase N, Okui T, Nagatsuka H, Ibaragi S.
Umemori K, et al. Among authors: eguchi t.
Oral Oncol. 2023 Jul;142:106433. doi: 10.1016/j.oraloncology.2023.106433. Epub 2023 May 24.
Oral Oncol. 2023.
PMID: 37236125
Free article.